课题基金 / 基金详情

Identifying Markers of AntiDepressant response: Advancing Precision Treatment of depression

Identifying Markers of AntiDepressant response: Advancing Precision Treatment of depression
识别抗抑郁反应的标志物：推进抑郁症的精准治疗
批准号：
387989
负责人：
Turecki Gustavo X
金额：
$14.52万
依托单位：
CIUSSS de l'Ouest-de-l'Ile-de-Montral-Douglas Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-07-01 至 2021-07-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=387989&lang=en
关键词：
Antidepressant Treatment Biomarkers Of Response Clinical Markers Epigenetics Major Depressive Disorder

项目摘要

项目成果

Turecki Gustavo X的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to study major depressive disorder (MDD), a highly prevalent disease that is associated with major socioeconomic burden. Although it is clear that MDD results from dysfunction of the brain, and over the last decades we have obtained important l
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular vesicles (EVs) as a window into the depressed brain: an investigation of brain-cell derived EVs
Single-cell, high-throughput characterization of the depressed brain
Canada Research Chair - Tier 1
  • 批准号：
    481064
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2022
  • 负责人：
    Turecki Gustavo X
  • 依托单位：
    McGill University
Extracellular vesicles (EVs) as a window into the depressed brain: an investigation of brain-cell derived EVs
海外基金